Nu-Med Plus (NUMD) Profit After Tax (QoQ) (2012 - 2025)
Nu-Med Plus (NUMD) Profit After Tax (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.45% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | 41.48% |
| Mar 31, 2025 | -88.85% |
| Dec 31, 2024 | 43.49% |
| Sep 30, 2024 | -8.04% |
| Jun 30, 2024 | 20.80% |
| Mar 31, 2024 | 61.44% |
| Dec 31, 2023 | -244.97% |
| Sep 30, 2023 | 32.54% |
| Jun 30, 2023 | 13.77% |
| Mar 31, 2023 | -166.20% |
| Dec 31, 2022 | 173.40% |
| Sep 30, 2022 | 0.03% |
| Jun 30, 2022 | -2.50% |
| Mar 31, 2022 | 49.57% |
| Dec 31, 2021 | 5.09% |
| Sep 30, 2021 | 51.21% |
| Jun 30, 2021 | 32.00% |
| Mar 31, 2021 | 27.69% |